UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549

NOTICE OF EFFECTIVENESS

Effective Date:June 07,
XTL Biopharmaceuticals (NASDAQ:XTLB)
Gráfico Histórico do Ativo
De Jun 2024 até Jul 2024 Click aqui para mais gráficos XTL Biopharmaceuticals.
XTL Biopharmaceuticals (NASDAQ:XTLB)
Gráfico Histórico do Ativo
De Jul 2023 até Jul 2024 Click aqui para mais gráficos XTL Biopharmaceuticals.

Notícias Xtl Biopharmaceuticals Ltd

Form 6-K - Report of foreign issuer [Rules 13a-16 and 15d-16]
Segunda, 22 de Julho de 2024 (10 horas atrás) • Edgar (US Regulatory)
Form 6-K - Report of foreign issuer [Rules 13a-16 and 15d-16]
Quarta, 12 de Junho de 2024 (1 mês atrás) • Edgar (US Regulatory)
Form 6-K - Report of foreign issuer [Rules 13a-16 and 15d-16]
Quarta, 5 de Junho de 2024 (2 meses atrás) • Edgar (US Regulatory)
XTL Entered Definitive Agreement to Acquire The Social Proxy
Quarta, 5 de Junho de 2024 (2 meses atrás) • GlobeNewswire Inc.
Form 6-K - Report of foreign issuer [Rules 13a-16 and 15d-16]
Segunda, 13 de Maio de 2024 (2 meses atrás) • Edgar (US Regulatory)
XTL To Aquire The Social Proxy
Quarta, 20 de Março de 2024 (4 meses atrás) • GlobeNewswire Inc.
Form 6-K - Report of foreign issuer [Rules 13a-16 and 15d-16]
Quarta, 15 de Novembro de 2023 (8 meses atrás) • Edgar (US Regulatory)
Form 6-K - Report of foreign issuer [Rules 13a-16 and 15d-16]
Sexta, 20 de Outubro de 2023 (9 meses atrás) • Edgar (US Regulatory)
XTL Biopharmaceuticals Confirms that it has not Experienced any Disruption to its Business Operations in Israel
Sexta, 20 de Outubro de 2023 (9 meses atrás) • GlobeNewswire Inc.
Form 6-K - Report of foreign issuer [Rules 13a-16 and 15d-16]
Quinta, 10 de Agosto de 2023 (11 meses atrás) • Edgar (US Regulatory)

Mais Notícias de Xtl Biopharmaceuticals Ltd

Seu Histórico Recente

COIN
PEPEXLUSD
PepeXL
Delayed Upgrade Clock